PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A fixed combination of extracts including common ash bark (Phytodolor/STW 1) demonstrated pharmacological efficacy in reducing the intake of non-steroidal anti-inflammatory drugs (NSAIDs) [PMID:17704984].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 8761637 (1996) — [New aero-allergens]. · Revue de pneumologie clinique
- 2.PMID: 32598444 (2020) — Canditate metabolites for ash dieback tolerance in Fraxinus excelsior. · Journal of experimental botany
- 3.PMID: 36835169 (2023) — Bio-Guided Isolation of Compounds from Fraxinus excelsior Leaves with Anti-Inflammatory Activity. · International journal of molecular sciences
- 4.PMID: 17016054 (2007) — Standardization of an ash (Fraxinus excelsior) pollen allergen extract. · International archives of allergy and immunology
- 5.PMID: 17704984 (2007) — Phytodolor--effects and efficacy of a herbal medicine. · Wiener medizinische Wochenschrift (1946)